EuroClonality is a European scientifically independent foundation aiming to promote continuous innovation and standardization of laboratory diagnostics in hemato-oncology with a special emphasis on clonality testing and supporting quality control and education in laboratory diagnostics. EuroClonality developed and standardized novel multiplex PCR assays for detection of immunoglobulin (IG) and T-cell receptor (TR) gene rearrangements. These assays are now widely used for the diagnosis of lymphoproliferative disorders.
In 2026, we will celebrate the 20th edition of the EuroClonality Workshop in Nijmegen! This milestone event marks an important moment in the history of our Workshop and will receive special attention.
For more details or visit our Workshop page for more information about the workshop and registration.
Since the start of the collaboration in 1996, the EuroClonality Consortium has developed, optimized, standardized and validated various new assays and related tools to improve diagnostic patient care.
Together with the Biomedical Quality Assurance Research Unit of the KU Leuven, EuroClonality organizes an annual External Quality Assessment scheme. All laboratories working with the EuroClonality/BIOMED-2 multiplex PCR assays for detection of IG/TR gene rearrangements can join this EQA scheme to evaluate their performance.
News
ESLHO, together with the independent scientific foundations EuroFlow, EuroClonality and EuroMRD, is an official EHA Specialized Working Group (SWG).